| Sherry J Hugi, CRNA | |
|
1209 Nw North Ridge Dr Ste B, Anesthesia Services Of Blue Springs, Blue Springs, MO 64015-6320 | |
| (816) 988-8415 | |
| (816) 988-8395 |
| Full Name | Sherry J Hugi |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 40 Years |
| Location | 1209 Nw North Ridge Dr Ste B, Blue Springs, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588764096 | NPI | - | NPPES |
| 916780257 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 072335 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Kansas City Pa | 1951206168 | 222 |
News Archive
People over 65 in the UK are to be offered a routine jab to help protect against diseases, including pneumonia, meningitis and septicaemia. Two in 1,000 over-65s are admitted to hospital with pneumococcal pneumonia each year and the infection can cause serious diseases.
Delivering on its commitment to develop and expand minimally invasive surgery technologies and capabilities, Medtronic plc announced the launch of its Signia Stapling System. The latest addition to the company's MIS portfolio, the Signia system provides surgeons with real-time feedback and automated responses to that real-time data.
Intellect Neurosciences, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent related to the Company's humanized monoclonal antibody, IN-N01, being developed as a disease-modifying treatment for Alzheimer's disease and other related indications.
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.
› Verified 4 days ago
| Entity Name | Anesthesia Associates Of Kansas City Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174504732 PECOS PAC ID: 1951206168 Enrollment ID: O20031201000810 |
News Archive
People over 65 in the UK are to be offered a routine jab to help protect against diseases, including pneumonia, meningitis and septicaemia. Two in 1,000 over-65s are admitted to hospital with pneumococcal pneumonia each year and the infection can cause serious diseases.
Delivering on its commitment to develop and expand minimally invasive surgery technologies and capabilities, Medtronic plc announced the launch of its Signia Stapling System. The latest addition to the company's MIS portfolio, the Signia system provides surgeons with real-time feedback and automated responses to that real-time data.
Intellect Neurosciences, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent related to the Company's humanized monoclonal antibody, IN-N01, being developed as a disease-modifying treatment for Alzheimer's disease and other related indications.
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.
› Verified 4 days ago
| Entity Name | Excel Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366559130 PECOS PAC ID: 1850397787 Enrollment ID: O20061017000539 |
News Archive
People over 65 in the UK are to be offered a routine jab to help protect against diseases, including pneumonia, meningitis and septicaemia. Two in 1,000 over-65s are admitted to hospital with pneumococcal pneumonia each year and the infection can cause serious diseases.
Delivering on its commitment to develop and expand minimally invasive surgery technologies and capabilities, Medtronic plc announced the launch of its Signia Stapling System. The latest addition to the company's MIS portfolio, the Signia system provides surgeons with real-time feedback and automated responses to that real-time data.
Intellect Neurosciences, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent related to the Company's humanized monoclonal antibody, IN-N01, being developed as a disease-modifying treatment for Alzheimer's disease and other related indications.
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sherry J Hugi, CRNA 1209 Nw North Ridge Dr Ste B, Anesthesia Services Of Blue Springs, Blue Springs, MO 64015-6320 Ph: (816) 988-8415 | Sherry J Hugi, CRNA 1209 Nw North Ridge Dr Ste B, Anesthesia Services Of Blue Springs, Blue Springs, MO 64015-6320 Ph: (816) 988-8415 |
News Archive
People over 65 in the UK are to be offered a routine jab to help protect against diseases, including pneumonia, meningitis and septicaemia. Two in 1,000 over-65s are admitted to hospital with pneumococcal pneumonia each year and the infection can cause serious diseases.
Delivering on its commitment to develop and expand minimally invasive surgery technologies and capabilities, Medtronic plc announced the launch of its Signia Stapling System. The latest addition to the company's MIS portfolio, the Signia system provides surgeons with real-time feedback and automated responses to that real-time data.
Intellect Neurosciences, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent related to the Company's humanized monoclonal antibody, IN-N01, being developed as a disease-modifying treatment for Alzheimer's disease and other related indications.
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.
› Verified 4 days ago
Timothy D Fundenberger, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1209 Nw North Ridge Dr Ste B, Anesthesia Services Of Blue Springs, Blue Springs, MO 64015 Phone: 816-988-8415 Fax: 816-988-8395 | |
Mr. Jeremy Michael Daves, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 201 Nw R D Mize Rd, Anesthesia Services Of Blue Springs/st. Mary's Medical, Blue Springs, MO 64014 Phone: 816-988-8415 Fax: 816-335-4003 | |
Mrs. Brenda Rae Rutherford, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 209 Nw North Ridge Drive, Suite B, Anesthesia Services Of Blue Springs, Blue Springs, MO 64015 Phone: 816-988-8415 Fax: 816-988-8395 | |
Dina Lynn Lutjen, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1209 Nw North Ridge Dr, Suite B, Blue Springs, MO 64015 Phone: 816-988-8415 Fax: 816-988-8395 | |
Denise A Wilson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1209 Nw North Ridge Dr Ste B, Anesthesia Services Of Blue Springs, Blue Springs, MO 64015 Phone: 816-988-8415 Fax: 816-988-8395 | |
Karen L. Graybill, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1209 Nw North Ridge Dr Ste B, Anesthesia Services Of Blue Springs, Blue Springs, MO 64015 Phone: 816-988-8415 Fax: 816-988-8395 |